Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Seeking Alpha
Monday, September 17, 2012 - 10:08am
tags:
asthma, Boston Scientific, GSK, Novartis, Merck, AstraZeneca, Bronchial Thermoplasty, Alair
Sirtex Deal Elevated With Liver Cancer Therapy: Real M&A
Bloomberg
Sunday, September 16, 2012 - 11:46am
tags:
Sirtex, liver cancer
3 Things to Watch With Teva Pharmaceutical
Daily Finance
Sunday, September 16, 2012 - 11:44am
tags:
Teva Pharmaceuticals
2 Stocks to Play This Long-Term Health-Care Trend
Motley Fool
Sunday, September 16, 2012 - 11:41am
tags:
Quest Diagnostics, LabCorp
China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
Seeking Alpha
Sunday, September 16, 2012 - 11:40am
tags:
WuXi PharmaTech, MedImmune, 3SBio, Hisun, Simcere, Merck, Qiagen, Lepu Medical Technology, Generon Corporation
Pfizer expanding force in China
The Day
Saturday, September 15, 2012 - 12:25pm
tags:
Pfizer
Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp.
The Street
Saturday, September 15, 2012 - 11:45am
tags:
lawsuits, Medicis
7 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, September 15, 2012 - 11:43am
tags:
Flamel, Questcor Pharmaceuticals, Eli Lilly, XenoPort, Valeant Pharmaceuticals, Acura Pharmaceuticals, Sanofi
GlaxoSmithKline takes stake in Response Genetics
bizjournals
Saturday, September 15, 2012 - 11:41am
tags:
GSK, Response Genetics
Impax and J&J settle Concerta patent lawsuits
Equities.com
Saturday, September 15, 2012 - 11:39am
tags:
Impax, JNJ, Concerta, generics, patents, lawsuits
2 Factors Will Keep Abbott Laboratories Bullish
Seeking Alpha
Saturday, September 15, 2012 - 11:19am
tags:
Abbott Laboratories
5 Healthcare Stocks That Could Boost Your Portfolio By 2013
Seeking Alpha
Saturday, September 15, 2012 - 11:18am
tags:
GSK, Theravance, JNJ, Pfizer, Neuralstem
Should This News Scare Amarin Investors?
Motley Fool
Saturday, September 15, 2012 - 11:17am
tags:
Amarin
Near-Term Catalyst Could Drive ChromaDex Shares Higher
Seeking Alpha
Saturday, September 15, 2012 - 11:17am
tags:
ChromaDex, nutraceutical
Pfizer Inc (PFE): Today's Featured Drugs Laggard
The Street
Saturday, September 15, 2012 - 11:14am
tags:
Pfizer
AstraZeneca in Neutral Lane
Yahoo/Zacks
Saturday, September 15, 2012 - 11:13am
tags:
AstraZeneca
ABT Dividend Yield Pushes Past 3%
Forbes
Saturday, September 15, 2012 - 9:43am
tags:
Abbott Laboratories
Buying Into Catalyst Pharma's Fast Tracked Vigabatrim On Friday
Seeking Alpha
Saturday, September 15, 2012 - 9:43am
tags:
Catalyst Pharmaceutical Partners, Vigabatrin, CPP-109, cocaine addiction
Biotechnology News: IntraPace's New Drug Stops You From Excessive Eating
Minyanville
Saturday, September 15, 2012 - 9:39am
tags:
IntraPace, Abiliti, weight loss, obesity
Healthcare Business Review: L’Oreal’s FDA WARNING, Dara’s SWISS Deal
Wall Street Cheat Street
Saturday, September 15, 2012 - 9:37am
tags:
L’Oreal, Neuralstem, DARA Biosciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.